Cipla Quality Chemical Industries Limited reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was UGX 267,432.35 million compared to UGX 284,539.94 million a year ago. Net income was UGX 24,050.6 million compared to net loss of UGX 10,538.24 million a year ago.

Basic earnings per share from continuing operations was UGX 6.59 compared to basic loss per share from continuing operations of UGX 2.89 a year ago.